Cencora, Inc. (LON:0HF3)
London flag London · Delayed Price · Currency is GBP · Price in USD
286.43
-3.32 (-1.15%)
At close: May 9, 2025

Cencora Revenue

Cencora had revenue of $75.45B USD in the quarter ending March 31, 2025, with 10.29% growth. This brings the company's revenue in the last twelve months to $310.23B, up 12.18% year-over-year. In the fiscal year ending September 30, 2024, Cencora had annual revenue of $293.96B with 12.12% growth.

Revenue (ttm)
$310.23B
Revenue Growth
+12.18%
P/S Ratio
0.17
Revenue / Employee
$6.74M
Employees
46,000
Market Cap
40.84B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024293.96B31.79B12.12%
Sep 30, 2023262.17B23.59B9.89%
Sep 30, 2022238.59B24.60B11.50%
Sep 30, 2021213.99B24.09B12.69%
Sep 30, 2020189.89B10.30B5.74%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings